Opinion
Video
Best Practices for Diagnosing Arrhythmia
Experts discuss how arrhythmia evaluation is tailored based on symptom frequency, severity, and patient risk, using a stepwise approach from short-term to extended monitoring to guide timely and effective diagnosis and management.
When evaluating a patient presenting with symptoms suggestive of arrhythmia, the initial diagnostic approach heavily depends on several factors including the patient’s age, comorbidities, symptom frequency, and severity. The clinician first considers whether an urgent diagnosis is needed to prevent adverse events such as hospitalization. For patients with frequent or accelerating symptoms, immediate diagnostic testing is prioritized to quickly guide treatment and avoid worsening outcomes. If symptoms occur very often, a short-term monitor like a 24-hour Holter is typically sufficient to capture relevant arrhythmias.
For patients with less frequent symptoms, longer monitoring—such as a 2-week event monitor—is often preferred. This extended duration balances thoroughness with practicality, increasing the chance of detecting intermittent arrhythmias without the invasiveness or complexity of implantable devices. Implantable loop recorders generally come into play only if noninvasive monitoring fails to yield a diagnosis and symptoms remain stable. Throughout this process, the urgency to start medications or anticoagulation depends on how well the diagnosis is established and the patient’s clinical stability.
Symptom characterization is crucial in guiding diagnostic decisions. Palpitations and syncope have different clinical implications, with syncope generally representing a higher risk that requires more urgent and detailed evaluation. The frequency and duration of symptoms also impact monitoring choices—daily palpitations may be caught with shorter monitoring, while infrequent, longer-lasting episodes may necessitate extended or specialized monitoring devices. Additionally, ambulatory cardiac monitors are useful not only for initial diagnosis but also for managing known conditions like atrial fibrillation. These monitors help assess rate control, evaluate the burden of arrhythmia post ablation, and optimize ongoing treatment plans.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
